Congo approves four experimental Ebola treatments to battle outbreak

Congo’s health ministry says four experimental treatments have been approved for use in the Ebola virus outbreak in its northeast.

The health ministry says ZMapp, Remdesivir, Favipiravir and Regn3450 – 3471 – 3479 now can be used. Health officials began using the mAb114 treatment on Aug. 11 on 10 patients and the ministry says they are doing well.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

Sign up for weekly health newsletter Sign Up

By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

The ministry says there are 75 confirmed Ebola cases and 27 probable ones. Of the 59 deaths, 32 have been confirmed as Ebola since the outbreak was announced on Aug. 1 in North Kivu province.

More than 1,600 people have been vaccinated.

Insecurity in the region, especially in what the World Health Organization calls “red zones” where several armed groups stage attacks, is hampering efforts to treat everyone.